Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fondaparinux in Acute Deep Vein Thrombosis
NCT00911157Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2008
- Primary completion
- Nov 2009
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of fondaparinux in deep vein thrombosis (DVT), sponsored by GSK. Started Jun 2008; status: completed.
02
Drugs
fondaparinux
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT00911157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911157.